Colonoscopy effects on serum prostate specific antigen levels

被引:4
|
作者
Barbatzas, C. [2 ]
Dellis, A. [1 ]
Grivas, I. [2 ]
Trakas, N. [3 ]
Ekonomou, A. [3 ]
Kostakopoulos, A. [1 ]
机构
[1] Univ Athens, Dept Urol, Athens, Greece
[2] Univ Athens, Dept Gastroenterol, Athens, Greece
[3] Sismanoglio Hosp, Microbiol Lab, Athens, Greece
关键词
Colonoscopy; Prostate specific antigen; Prostatic cancer; Screening;
D O I
10.1023/B:UROL.0000034674.19318.86
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: To evaluate the colonoscopy effects on serum levels of prostate specific antigen (PSA) and PSA ratio. Subjects and methods: Thirty men were studied (median age 68 years, range 32-89). All of them had their serum PSA (total and free) measured 24 hours prior to colonoscopy and also 24 hours, 7 and 30 days after procedure. Results: 14 of 30 (47%) patients, had significantly (p = 0.045) increased Total PSA levels 24 hours after the procedure, 14 (47%) patients had insignificantly (p = 0.139) increased levels 7 days after, while 13 (43%) of them had insignificantly (p = 0,061) increased levels 30 days after colonoscopy. In 7 patients (23%), with total PSA levels in the "gray zone" (4-10 ng/ml) before colonoscopy, a near significant (p = 0.063) raise in PSA ratio was also observed 24 hours after. Conclusion: Flexible colonoscopy affect serum PSA (free and total) levels in certain patients. Special attention must be given to those patients with PSA levels in the "gray zone" before colonoscopy.
引用
收藏
页码:203 / 206
页数:4
相关论文
共 50 条
  • [31] Impact of kidney and liver metabolism on serum prostate specific antigen levels
    Morote, J
    Lorente, JA
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1995, 10 (04): : 236 - 237
  • [32] The Relationship Between Metformin and Serum Prostate-Specific Antigen Levels
    Jayalath, Viranda H.
    Ireland, Christopher
    Fleshner, Neil E.
    Hamilton, Robert J.
    Jenkins, David J. A.
    PROSTATE, 2016, 76 (15): : 1445 - 1453
  • [33] Serum prostate specific antigen levels following transurethral microwave thermotherapy
    Gretzer, MB
    Trock, BT
    Utz, W
    Ugarte, R
    Kaplan, S
    Larson, T
    Blute, M
    Roehrborn, C
    Partin, AW
    JOURNAL OF UROLOGY, 2003, 169 (04): : 468 - 468
  • [34] The Efficiency of the Serum Prostate Specific Antigen Levels in Diagnosing Prostatic Enlargements
    Ingle, S. P.
    Ramona, Ingle
    Sukesh
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (01) : 82 - 84
  • [35] Effect of hemodialysis on serum complexed prostate-specific antigen levels
    Tarhan, Fatih
    Orcun, Asuman
    Kucukercan, Inci
    Camursoy, Nazan
    Kuyumcuoglu, Ugur
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2007, 41 (05): : 382 - 386
  • [36] Serum prostate-specific antigen levels and prostate cancer risk in a multiethnic population
    Chou, Alisha
    Darst, Burcu F.
    Wilkens, Lynne R.
    Le Marchand, Loic
    Lilja, Hans G.
    Conti, David V.
    Haiman, Christopher A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [37] Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy
    Janbaziroudsari, Hamid
    Mirzaei, Arezoo
    Maleki, Nasrollah
    BULLETIN DU CANCER, 2016, 103 (09) : 730 - 734
  • [38] Serum prostate specific antigen levels after green laser enucleation of the prostate (GreenLEP)
    Peyronnet, Benoit
    Rijo, Enrique
    Misrai, Vincent
    Tabatabaei, Shahin
    Ferrari, Giovanni
    Gomez-Sancha, Fernando
    NEUROUROLOGY AND URODYNAMICS, 2019, 38 : S205 - S206
  • [39] Effects of prostate manipulation on serum total and free prostate specific antigen, and free-to-total prostate specific antigen ratio
    Lin, Yun-Hua
    Jiang, Yong-Guang
    Li, Ming-Chuan
    Luo, Yong
    Wang, Jun-Sheng
    SAUDI MEDICAL JOURNAL, 2010, 31 (09) : 999 - 1004
  • [40] Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels
    Cramer, SD
    Chang, BL
    Rao, A
    Hawkins, GA
    Zheng, SL
    Wade, WN
    Cooke, RT
    Thomas, LN
    Bleecker, ER
    Catalona, WJ
    Sterling, DA
    Meyers, DA
    Ohar, J
    Xu, JF
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (14): : 1044 - 1053